MET and renal carcinoma: MET inhibits pulmonary metastasis and increases NK cell activity [209], exerts an antiproliferative action against ovarian tumor cells (HEY, CAOV-3, SW626), delays cell moving [16,245], and blocks the proliferation of human renal cancer cells (Caki-2) [281].